Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
about
Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults.Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database.Veteran subjects willingness to participate in schizophrenia clinical trials.Response from the authors.
P2860
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Challenges in the design and c ...... eness trials in schizophrenia.
@en
Challenges in the design and c ...... eness trials in schizophrenia.
@nl
type
label
Challenges in the design and c ...... eness trials in schizophrenia.
@en
Challenges in the design and c ...... eness trials in schizophrenia.
@nl
prefLabel
Challenges in the design and c ...... eness trials in schizophrenia.
@en
Challenges in the design and c ...... eness trials in schizophrenia.
@nl
P2093
P2860
P356
P1433
P1476
Challenges in the design and c ...... eness trials in schizophrenia.
@en
P2093
CSP 555 Research Group
Carla Neal
Danielle Valley
Grant D Huang
John H Krystal
Julia E Vertrees
Louis Fiore
Matthew H Liang
Paul G Barnett
Robert Lew
P2860
P304
P356
10.1177/1740774510392931
P577
2011-01-26T00:00:00Z